category,datetime,headline,id,image,related,source,summary,url
company,1768495201,Why Pfizer Inc. (PFE) is One of the Best Affordable Stocks Under $30,138122795,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,PFE,Yahoo,"Pfizer Inc. (NYSE:PFE) is one of the best affordable stocks under $30. Pfizer Inc. (NYSE:PFE) announced on January 10 positive results from Cohort 3, which is a separate randomized cohort of the pivotal BREAKWATER trial, evaluating BRAFTOVI® in combination with cetuximab and FOLFIRI in patients with previously untreated metastatic colorectal cancer with a BRAF V600E […]",https://finnhub.io/api/news?id=2abdc9ab1c2df162d72524955c8023c1cfaa57b1debc9a811903c42df2b363b7
company,1768494900,Pfizer Inc. stock outperforms competitors on strong trading day,138209707,,PFE,MarketWatch,Pfizer Inc. stock outperforms competitors on strong trading day,https://finnhub.io/api/news?id=b83eb3a5e22c353e93e8212cb316cf2a1a11ac5999e68d09c465c7afdaf62346
company,1768484280,Will DefenCath Continue to Aid CorMedix's Top Line in Q4 Earnings?,138121689,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,PFE,Yahoo,"CRMD's DefenCath, the only FDA-approved antimicrobial catheter lock, saw higher outpatient dialysis use in the fourth quarter, likely driving revenues.",https://finnhub.io/api/news?id=21d26c99abb1b74216c4fc6e76b55af7973103941a08a65802e726d42796613a
company,1768479722,Factbox-Major deals involving U.S. drugmakers and biotechs over the past decade,138120717,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,PFE,Yahoo,"Jan 15 (Reuters) - Boston Scientific is buying medical equipment maker Penumbra in a deal valued at about $14.5 billion, to expand its vascular pipeline.",https://finnhub.io/api/news?id=bbfd391d9f8f10e71e49dace0086a3bd81f1b55ce02d42df5ea273c7dd6618c5
company,1768467513,Pfizer: The Most Intriguing Value Play Of 2026,138120969,,PFE,SeekingAlpha,,https://finnhub.io/api/news?id=9889cc6cd2341988bf46a7e8ebc0bf9ecfd15292636be55cfacda8e7e852fbb5
company,1768455872,3SBio Sees More Business Development Deals,138118370,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,PFE,Yahoo,"Tony He, CFO of the Chinese biopharmaceutical firm 3SBio, discusses his outlook for dealmaking and the progress of a record licensing deal the company struck with Pfizer last year. He speaks on ""Bloomberg: The China Show"" from San Francisco, where the JPMorgan Healthcare Conference is taking place.",https://finnhub.io/api/news?id=f963582c804e948817594323a7b34b77cd63f709fa8c1be01ff8b7bdce6c9609
